XML 30 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-Based Compensation
9 Months Ended
Dec. 31, 2015
Share-based Compensation [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(12)  STOCK-BASED COMPENSATION
Valuation Assumptions
We estimate the fair value of stock-based payment awards on the date of grant. We recognize compensation costs for stock-based payment awards to employees based on the grant-date fair value over the service period for which such awards are expected to vest. For awards with only service conditions that have a graded vesting schedule, we recognize compensation costs on a straight-line basis over the requisite service period for the entire award.

The determination of the fair value of market-based restricted stock units, stock options and ESPP is affected by assumptions regarding subjective and complex variables. Generally, our assumptions are based on historical information and judgment is required to determine if historical trends may be indicators of future outcomes. We determine the fair value of our stock-based payment awards as follows:

Restricted Stock Units, Restricted Stock, and Performance-Based Restricted Stock Units. The fair value of restricted stock units, restricted stock, and performance-based restricted stock units (other than market-based restricted stock units) is determined based on the quoted market price of our common stock on the date of grant. Performance-based restricted stock units include grants made in connection with certain acquisitions.

Market-Based Restricted Stock Units. Market-based restricted stock units consist of grants of performance-based restricted stock units to certain members of executive management that vest contingent upon the achievement of pre-determined market and service conditions (referred to herein as “market-based restricted stock units”). The fair value of our market-based restricted stock units is determined using a Monte-Carlo simulation model. Key assumptions for the Monte-Carlo simulation model are the risk-free interest rate, expected volatility, expected dividends and correlation coefficient.

Stock Options and Employee Stock Purchase Plan. The fair value of stock options and stock purchase rights granted pursuant to our equity incentive plans and our 2000 Employee Stock Purchase Plan (“ESPP”), respectively, is determined using the Black-Scholes valuation model based on the multiple-award valuation method. Key assumptions of the Black-Scholes valuation model are the risk-free interest rate, expected volatility, expected term and expected dividends. The risk-free interest rate is based on U.S. Treasury yields in effect at the time of grant for the expected term of the option. Expected volatility is based on a combination of historical stock price volatility and implied volatility of publicly-traded options on our common stock. Expected term is determined based on historical exercise behavior, post-vesting termination patterns, options outstanding and future expected exercise behavior.
There were an insignificant number of stock options granted during the three and nine months ended December 31, 2015.
The estimated assumptions used in the Black-Scholes valuation model to value our stock option grants and ESPP were as follows:
 
 
Stock Option Grants
 
ESPP
 
 
Nine Months Ended
December 31,
 
Nine Months Ended
December 31,
 
 
2014
 
2015
 
2014
Risk-free interest rate
 
1.1 -1.9%

 
0.3 - 0.4%

 
0.04 - 0.1%

Expected volatility
 
36 - 40%

 
32
%
 
34 - 35%

Weighted-average volatility
 
38
%
 
32
%
 
35
%
Expected term
 
4.5 years

 
6 - 11.5 months

 
6 - 12 months

Expected dividends
 
None

 
None

 
None



There were no market-based restricted stock units granted during the three months ended December 31, 2015 and 2014.

Stock-Based Compensation Expense
Employee stock-based compensation expense recognized during the three months ended December 31, 2015 and 2014 was calculated based on awards ultimately expected to vest and has been reduced for estimated forfeitures. In subsequent periods, if actual forfeitures differ from those estimates, an adjustment to stock-based compensation expense is recognized at that time.

The following table summarizes stock-based compensation expense resulting from stock options, restricted stock, restricted stock units, performance-based restricted stock units, market-based restricted stock units, and the ESPP included in our Condensed Consolidated Statements of Operations (in millions):
 
Three Months Ended
December 31,
 
Nine Months Ended
December 31,
 
2015
 
2014
 
2015
 
2014
Cost of revenue
$

 
$
1

 
$
1

 
$
2

Research and development
26

 
$
22

 
77

 
61

Marketing and sales
5

 
6

 
17

 
16

General and administrative
11

 
10

 
36

 
29

Stock-based compensation expense
$
42

 
$
39

 
$
131

 
$
108


During the three and nine months ended December 31, 2015 and 2014, we did not recognize any benefit from income taxes related to our stock-based compensation expense.
As of December 31, 2015, our total unrecognized compensation cost related to stock options was $10 million and is expected to be recognized over a weighted-average service period of 1.7 years. As of December 31, 2015, our total unrecognized compensation cost related to restricted stock, restricted stock units, and market-based restricted stock units (collectively referred to as “restricted stock rights”) was $277 million and is expected to be recognized over a weighted-average service period of 1.4 years. Of the $277 million of unrecognized compensation cost, $31 million relates to market-based restricted stock units.
During the three and nine months ended December 31, 2015, we recognized $8 million and $73 million, respectively, of excess tax benefit from stock-based compensation deductions; this amount is reported in the financing activities on our Condensed Consolidated Statement of Cash Flows.
Stock Options
The following table summarizes our stock option activity for the nine months ended December 31, 2015: 
 
 
Options
(in thousands)
 
Weighted-
Average
Exercise Prices
 
Weighted-
Average
Remaining
Contractual
Term  (in years)
 
Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2015
 
4,920

 
$
37.44

 
 
 
 
Granted
 
4

 
66.72

 
 
 
 
Exercised
 
(1,473
)
 
43.92

 
 
 
 
Forfeited, cancelled or expired
 
(52
)
 
35.76

 
 
 
 
Outstanding as of December 31, 2015
 
3,399

 
$
34.69

 
5.78
 
$
116

Vested and expected to vest
 
3,241

 
$
34.84

 
5.67
 
$
110

Exercisable as of December 31, 2015
 
2,263

 
$
36.18

 
4.57
 
$
74


The aggregate intrinsic value represents the total pre-tax intrinsic value based on our closing stock price as of December 31, 2015, which would have been received by the option holders had all the option holders exercised their options as of that date. The weighted-average grant date fair values of stock options granted during nine months ended December 31, 2014 was $12.01. We issue new common stock from our authorized shares upon the exercise of stock options.
Restricted Stock Rights
The following table summarizes our restricted stock rights activity, excluding market-based restricted stock unit activity which is discussed below, for the nine months ended December 31, 2015: 
 
 
Restricted
Stock Rights
(in thousands)
 
Weighted-
Average Grant
Date Fair Values
Balance as of March 31, 2015
 
10,855

 
$
26.20

Granted
 
2,743

 
64.45

Vested
 
(5,520
)
 
21.66

Forfeited or cancelled
 
(816
)
 
34.16

Balance as of December 31, 2015
 
7,262

 
$
43.20



The weighted-average grant date fair values of restricted stock rights granted during the three and nine months ended December 31, 2015 were $70.57 and $64.45, respectively.
Market-Based Restricted Stock Units
Our market-based restricted stock units vest contingent upon the achievement of pre-determined market and service conditions. If these market conditions are not met but service conditions are met, the market-based restricted stock units will not vest; however, any compensation expense we have recognized to date will not be reversed. The number of shares of common stock to be received at vesting will range from zero percent to 200 percent of the target number of market-based restricted stock units based on our total stockholder return (“TSR”) relative to the performance of companies in the NASDAQ-100 Index for each measurement period, generally over a one-year, two-year cumulative and three-year cumulative period. In the table below, we present shares granted at 100 percent of target of the number of market-based restricted stock units that may potentially vest. The maximum number of common shares that could vest is approximately 0.8 million for market-based restricted stock units granted during the nine months ended December 31, 2015. As of December 31, 2015, the maximum number of shares that could vest is approximately 1.3 million for market-based restricted stock units outstanding.
The following table summarizes our market-based restricted stock unit activity for the nine months ended December 31, 2015: 
 
 
Market-Based
Restricted  Stock
Units
(in thousands)
 
Weighted-
Average  Grant
Date Fair Value
Balance as of March 31, 2015
 
663

 
$
31.82

Granted
 
395

 
79.81

Vested
 
(742
)
 
25.77

Vested above target
 
371

 
25.77

Forfeited or cancelled
 
(51
)
 
40.10

Balance as of December 31, 2015
 
636

 
$
64.49


Stock Repurchase Program
In May 2014, a special committee of our Board of Directors, on behalf of the full Board of Directors, authorized a two-year program to repurchase up to $750 million of our common stock. Since inception, we repurchased approximately 9.2 million shares for approximately $394 million under this program.
 
In May 2015, our Board of Directors authorized a program to repurchase up to $1 billion of our common stock. This stock repurchase program, which expires on May 31, 2017, supersedes and replaces the stock repurchase authorization approved in May 2014. Under the May 2015 program, we may purchase stock in the open market or through privately-negotiated transactions in accordance with applicable securities laws, including pursuant to pre-arranged stock trading plans. The timing and actual amount of the stock repurchases will depend on several factors including price, capital availability, regulatory requirements, alternative investment opportunities and other market conditions. We are not obligated to repurchase any specific number of shares under this program and it may be modified, suspended or discontinued at any time.

During the three and nine months ended December 31, 2015, we repurchased approximately 1.8 million and 5.8 million shares for approximately $126 million and $384 million respectively. We continue to actively repurchase shares.

The following table summarizes total shares repurchased during the three and nine months ended December 31, 2015 and 2014:
 
May 2014 Program
 
May 2015 Program
 
Total
(in millions)
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
Three months ended December 31, 2015

 
$

 
1.8
 
$
126

 
1.8
 
$
126

Nine months ended December 31, 2015
1.0

 
$
57

 
4.8
 
$
327

 
5.8
 
$
384

Three months ended December 31, 2014
2.5
 
$
97

 

 
$

 
2.5
 
$
97

Nine months ended December 31, 2014
6.5
 
$
242

 

 
$

 
6.5
 
$
242